...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Prevalence of Anti-Gelatin IgE Antibodies in People With Anaphylaxis After Measles-Mumps-Rubella Vaccine in the United States
【24h】

Prevalence of Anti-Gelatin IgE Antibodies in People With Anaphylaxis After Measles-Mumps-Rubella Vaccine in the United States

机译:在美国麻疹-腮腺炎-风疹疫苗接种后有过敏反应的人群中,抗明胶IgE抗体的患病率

获取原文
           

摘要

Objective. Anaphylaxis after immunization, although rare, is serious and potentially life-threatening. Understanding risk factors for this reaction is therefore important. Gelatin is added to many vaccines as a heat stabilizer. Japanese researchers have demonstrated a strong association between immediate hypersensitivity reactions to measles, mumps, rubella, varicella, and Japanese encephalitis immunizations and subsequent detection of anti-gelatin immunoglobulin E (IgE) antibodies. They suggested that previous receipt by these patients of diphtheria-tetanus-acellular pertussis vaccines with trace amounts of gelatin was responsible for the sensitization. We aimed to assess whether a similar association exists for vaccinees in the United States who reported anaphylaxis after receipt of measles-mumps-rubella (MMR) or measles vaccines and to review recent trends in reporting of hypersensitivity reactions.Methods. We conducted a retrospective case-control study. Cases of anaphylaxis that met a predefined case definition were identified from the US Vaccine Adverse Event Reporting System (VAERS). Mayo Clinic patients who received MMR vaccine uneventfully served as controls. The study subjects were interviewed to obtain the history of allergies. Sera from study subjects and their matched controls were tested for IgE antibodies to gelatin, whole egg, and vaccine viral antigens using solid-phase radioimmunoassay. Data from the Biologics Surveillance System on annual numbers of doses of MMR and varicella vaccines distributed in the United States were used to evaluate possible changes in reporting of selected allergic adverse events.Results. Fifty-seven study subjects were recruited into the study and interviewed. Of these, 22 provided serum samples for IgE testing. Twenty-seven subjects served as a comparison group and provided a sample for IgE testing; 21 of these completed an allergy history questionnaire. Self-reported history of food allergies was present more frequently in the interviewed study subjects than in the controls, whereas the proportions of people with other characteristics were similar in both groups. None of the interviewed people had a history of food allergy to gelatin. The level of anti-gelatin IgE antibodies was significantly higher among study subjects than among controls, whereas the levels of IgE antibodies against egg and all 3 viral antigens did not differ significantly. Of 22 study subjects, 6 (27%) tested positive for anti-gelatin IgE, whereas none of the 27 controls did. The rate of anaphylactic reactions reported to VAERS after measles virus-containing immunization in the United States between 1991 and 1997 is 1.8 per 1 million doses distributed. No substantial increase in the number of reported allergic events after frequently used gelatin containing MMR and varicella vaccines could be observed during the first 4 years (1997–2000) since the introduction of diphtheria-tetanus-acellular pertussis vaccines for use in infancy.Conclusion. Anaphylactic reactions to MMR in the United States are rare. The reporting rate has the same order of magnitude as estimates from other countries. Almost one fourth of patients with reported anaphylaxis after MMR seem to have hypersensitivity to gelatin in the vaccine. They may be at higher risk of developing anaphylaxis to subsequent doses of other gelatin-containing vaccines. These people should seek an allergy evaluation before such immunization.
机译:目的。免疫接种后的过敏反应虽然很少见,但却是严重的,并且可能危及生命。因此,了解此反应的危险因素很重要。明胶是作为热稳定剂添加到许多疫苗中的。日本研究人员已证明,对麻疹,腮腺炎,风疹,水痘和日本脑炎免疫接种的超敏反应与随后的抗明胶免疫球蛋白E(IgE)抗体的检测之间存在密切的联系。他们认为,这些患者以前曾接受过微量明胶的白喉-破伤风-无细胞百日咳疫苗的致敏作用。我们旨在评估在美国在接种麻疹-腮腺炎-风疹(MMR)或麻疹疫苗后报告有过敏反应的疫苗上是否存在类似的协会,并回顾超敏反应报告的最新趋势。我们进行了回顾性病例对照研究。从美国疫苗不良事件报告系统(VAERS)确定了符合预定义病例定义的过敏反应病例。接受MMR疫苗治疗的Mayo诊所患者作为对照。对研究对象进行访谈以获取过敏史。使用固相放射免疫测定法测试了来自研究对象及其配对对照的血清的明胶,全蛋和疫苗病毒抗原的IgE抗体。来自美国生物制品监视系统的有关在美国分发的MMR和水痘疫苗的年度剂量数据的数据用于评估报告的某些过敏性不良事件的可能变化。研究招募了57名研究对象并进行了访谈。其中,有22个提供了用于IgE测试的血清样本。二十七名受试者作为比较组,并提供了用于IgE测试的样本;其中21人完成了过敏史调查表。自我报告的食物过敏史在受访者中比在对照组中更为常见,而两组中具有其他特征的人的比例相似。没有受访者对明胶有食物过敏史。研究对象中的抗明胶IgE抗体水平明显高于对照组,而针对鸡蛋和所有3种病毒抗原的IgE抗体水平则无显着差异。在22名研究对象中,有6名(27%)的抗明胶IgE测试呈阳性,而27名对照中没有一个。在1991年至1997年间,美国含麻疹病毒的免疫接种后报告给VAERS的过敏反应率为1.8 /百万剂。自从在婴儿期引入白喉-破伤风-无细胞百日咳疫苗以来的头4年(1997-2000年),在经常使用的含明胶的MMR和水痘疫苗后,已报道的过敏事件数量没有显着增加。结论。在美国,对MMR的过敏反应很少。报告率与其他国家的估计值具有相同的数量级。据报道,MMR后有过敏反应的患者中,近四分之一似乎对疫苗中的明胶过敏。他们可能会对随后剂量的其他含明胶疫苗产生过敏反应的风险更高。这些人应在进行此类免疫接种之前寻求过敏评估。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号